Order of the Court (Eighth Chamber), 14 November 2013
Astrazeneca AB v Comptroller General of Patents, Designs and Trade Marks
Request for a preliminary ruling from the High Court of Justice (England and Wales), Chancery Division (Patents Court)
Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 13(1) — Concept of ‘first authorisation to place [a product] on the market in the Community’ — Authorisation issued by the Swiss Institute for Medicinal Products (Swissmedic) — Automatic recognition in Liechtenstein — Authorisation issued by the European Medicines Agency — Period of validity of a certificate
Case C‑617/12
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Order
ECLI:EU:C:2013:761 |
|
|